Metagenomi, Inc.
MGX
$1.56
-$0.05-2.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.44% | 20.49% | -7.01% | -24.64% | -74.81% |
| Total Depreciation and Amortization | -0.82% | -1.69% | -7.05% | 7.11% | 4.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.34% | 68.66% | -71.96% | 234.35% | -14.04% |
| Change in Net Operating Assets | 28.97% | -248.33% | 85.26% | -23.12% | 39.49% |
| Cash from Operations | -0.01% | 6.97% | 13.07% | 1.36% | -1.25% |
| Capital Expenditure | 41.73% | 55.90% | 13.77% | 72.17% | -80.45% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 43.18% | -23.40% | -13.38% | 473.40% | 37.48% |
| Cash from Investing | 43.47% | -22.87% | -13.37% | 419.51% | 31.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 75.79% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 32.00% | -257.14% | -- | -- | -- |
| Cash from Financing | -12.65% | -115.58% | -- | 100.00% | 75.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 352.58% | -229.63% | -20.27% | 106.29% | 12.84% |